Bacterial Eavesdropping for Fast Antibiotic Susceptibility Testing
Antimicrobial resistance (AMR) is a global health problem, endangering millions of lives. Rapid Antimicrobial Susceptibility Testing (AST) plays a crucial role in determining the type and concentration of antibiotics required to inhibit the growth of a pathogen. However, the major issue with the current AST solutions is that they are slow in delivering results, needing 24h to a few days, leading to mis-prescriptions and/or over-prescriptions and severely impacting treatment outcomes.
With the European Transition Grant we aim at performing antibiotic susceptibility testing in less than an hour at the level of single bacteria on clinical samples.
Earlier correct prescription reduces patients side effects, shortens the time of illness and contributes to tracking, reducing, and managing the spread of infections and antimicrobial resistance.
Better logistics for clinical samples with faster time to result. No need to store patient samples for days in
incubators and fridges.
The right antibiotic at the right time reduces healthcare costs and reduces environmental footprint associated with patient treatment, by shorter hospital stay and lower waste production.
This project is funded by the European Commission under grant agreement no. 10113671.
